Creo Medical Limited (CREO.L) Stock Analysis & Winston Score

Creo Medical is a UK-based medical device company that makes advanced surgical tools used by doctors during endoscopy procedures — a type of examination where a small camera is inserted into the body. Its main product line, called CROMA, uses microwave and radiofrequency energy to cut and treat tissue inside the digestive tract without traditional open surgery. The company sells primarily to hospitals and specialist clinicians across Europe and other international markets. Creo Medical earns revenue by selling its devices and the single-use accessories that go with them, meaning hospitals must keep buying consumables each time the tools are used. The company is still small, with a market cap around $100 million, and has not yet reached profitability — its deeply negative operating margin reflects heavy spending on sales, clinical trials, and building out its commercial infrastructure. The key challenge ahead is scaling revenue fast enough to reach breakeven before needing additional funding, which remains a significant risk for investors.